These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22739257)

  • 1. Association of race with cumulative exposure to statins in dialysis.
    Wetmore JB; Mahnken JD; Rigler SK; Ellerbeck EF; Mukhopadhyay P; Hou Q; Shireman TI
    Am J Nephrol; 2012; 36(1):90-6. PubMed ID: 22739257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of race on cumulative exposure to antihypertensive medications in dialysis.
    Wetmore JB; Mahnken JD; Rigler SK; Ellerbeck EF; Mukhopadhyay P; Hou Q; Shireman TI
    Am J Hypertens; 2013 Feb; 26(2):234-42. PubMed ID: 23382408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geographic variation in HMG-CoA reductase inhibitor use in dialysis patients.
    Wetmore JB; Mahnken JD; Mukhopadhyay P; Hou Q; Ellerbeck EF; Rigler SK; Spertus JA; Shireman TI
    J Gen Intern Med; 2012 Nov; 27(11):1475-83. PubMed ID: 22696256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of medication synchronization programs on proportion of days covered (PDC) scores and Medicare Part D medication-related adherence metrics.
    Bernard K; Cowles B; McCall K; Henningsen RM; O'Toole M; Tu C
    J Am Pharm Assoc (2003); 2019; 59(3):343-348. PubMed ID: 30940515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.
    McWilliams JM; Najafzadeh M; Shrank WH; Polinski JM
    JAMA Cardiol; 2017 Sep; 2(9):1019-1023. PubMed ID: 28700790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis.
    Degli Esposti L; Saragoni S; Batacchi P; Benemei S; Geppetti P; Sturani A; Buda S; Degli Esposti E
    Clin Ther; 2012 Jan; 34(1):190-9. PubMed ID: 22284998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying adherent patients to newly initiated statins using previous adherence to chronic medications.
    Majd Z; Mohan A; Paranjpe R; Abughosh SM
    J Manag Care Spec Pharm; 2021 Feb; 27(2):186-197. PubMed ID: 33506725
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of an intervention to increase statin use in medicare members who qualified for a medication therapy management program.
    Stockl KM; Tjioe D; Gong S; Stroup J; Harada AS; Lew HC
    J Manag Care Pharm; 2008; 14(6):532-40. PubMed ID: 18693777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in cholesterol management among states in relation to health insurance and race/ethnicity across the United States.
    Hsia SH; Desnoyers ML; Lee ML
    J Clin Lipidol; 2013; 7(6):675-82. PubMed ID: 24314367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG CoA reductase inhibitors (statins) for dialysis patients.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Nigwekar SU; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD004289. PubMed ID: 24022428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study.
    Yang Y; Thumula V; Pace PF; Banahan BF; Wilkin NE; Lobb WB
    Clin Ther; 2009 Oct; 31(10):2178-88; discussion 2150-1. PubMed ID: 19922889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription drug benefits and use of guideline recommended medications by elderly Medicare beneficiaries with diabetes mellitus.
    Tjia J; Briesacher BA
    J Am Geriatr Soc; 2008 Oct; 56(10):1879-86. PubMed ID: 18771456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications.
    Axon DR; Vaffis S; Chinthammit C; Lott BE; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1529-1537. PubMed ID: 33251989
    [No Abstract]   [Full Text] [Related]  

  • 15. Patterns of medication adherence in a multi-ethnic cohort of prevalent statin users diagnosed with breast, prostate, or colorectal cancer.
    Banegas MP; Emerson MA; Adams AS; Achacoso NS; Chawla N; Alexeeff S; Habel LA
    J Cancer Surviv; 2018 Dec; 12(6):794-802. PubMed ID: 30338462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients.
    Mason NA; Bailie GR; Satayathum S; Bragg-Gresham JL; Akiba T; Akizawa T; Combe C; Rayner HC; Saito A; Gillespie BW; Young EW
    Am J Kidney Dis; 2005 Jan; 45(1):119-26. PubMed ID: 15696451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients.
    Seliger SL; Weiss NS; Gillen DL; Kestenbaum B; Ball A; Sherrard DJ; Stehman-Breen CO
    Kidney Int; 2002 Jan; 61(1):297-304. PubMed ID: 11786112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin use and hip fractures in U.S. kidney transplant recipients.
    Vangala C; Lenihan CR; Montez-Rath ME; Nair SS; Navaneethan SD; Ramanathan V; Winkelmayer WC
    BMC Nephrol; 2017 May; 18(1):145. PubMed ID: 28460645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
    Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
    JAMA Cardiol; 2017 Jan; 2(1):47-54. PubMed ID: 27829091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Race and Socioeconomic Differences Associated With Changes in Statin Eligibility Under the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
    Verma AA; Jimenez MP; Subramanian SV; Sniderman AD; Razak F
    Circ Cardiovasc Qual Outcomes; 2017 Sep; 10(9):. PubMed ID: 28912201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.